Event
BIOE Seminar: Autonomous Therapy Delivery via Contained Bacteria
Friday, December 11, 2026
9:00 a.m.
A. James Clark Hall, Room #2121
Sara Molinari
saramol@umd.edu
David Mooney
Professor
Harvard's Wyss Institute
Autonomous Therapy Delivery via Contained Bacteria
Abscract
Microbes are increasingly utilized as living therapeutics, yet their uncontrolled dissemination in the body is a clinical roadblock. We are developing implantable hydrogels that encapsulate and confine bacteria, and genetic engineering of embedded bacteria allows environmental sensing and on-demand therapeutic release capabilities, providing autonomous treatment.
Bio
David Mooney is the Robert Pinkas Family Professor of Bioengineering and a Core Faculty Member of the Wyss Institute, Harvard University. He is a member of National Academies of Engineering and Medicine and a Fellow of the National Academy of Inventors. Dave has mentored over 140 Ph.D. students and post-doctoral fellows. He is an inventor on over 85 US patents, and a number have been licensed, leading to commercialized products. His lab elucidates how cells sense and respond to signals in their environment, and then develops strategies that exploit this knowledge to regulate cells in the body. They were the first to demonstrate that the mechanical properties of 3D substrates regulate stem cell differentiation, and developed the first implantable biomaterial cancer vaccine, which progressed to clinical trials.
